MARKETING ANALYSIS OF THE ASSORTMENT OF DICLOFENAC SODIUM DRUGS ON THE PHARMACEUTICAL MARKET OF UKRAINE
DOI:
https://doi.org/10.30890/2567-5273.2023-26-04-065Ключові слова:
diclofenac sodium, non-steroidal anti-inflammatory drug, marketing analysis, assortmentАнотація
The article highlights the problems of the development and progression of rheumatic diseases, with damage to connective tissue, which leads to organ damage and loss of functional capacity. The main direction of conservative treatment is the use of nonsteMetrics
Посилання
Adami G, Fassio A, Rossini M, Caimmi C, Giollo A, Orsolini G, Viapiana O, Gatti D. Osteoporosis in Rheumatic Diseases. Int J Mol Sci. 2019 Nov 22;20(23):5867. doi: 10.3390/ijms20235867. PMID: 31766755; PMCID: PMC6928928.
Saas P, Toussirot E, Bogunia-Kubik K. Editorial: Recent Advances in Potential Biomarkers for Rheumatic Diseases and in Cell-Based Therapies in the Management of Inflammatory Rheumatic Diseases. Front Immunol. 2022 Jan 12;12:836119. doi: 10.3389/fimmu.2021.836119. PMID: 35095936; PMCID: PMC8789740.
Schinocca C, Rizzo C, Fasano S, Grasso G, La Barbera L, Ciccia F, Guggino G. Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview. Front Immunol. 2021 Feb 22;12:637829. doi: 10.3389/fimmu.2021.637829. PMID: 33692806; PMCID: PMC7937623.
Shapira Y, Agmon-Levin N, Shoenfeld Y. Geoepidemiology of autoimmune rheumatic diseases. Nat Rev Rheumatol. 2010 Aug;6(8):468-76. doi: 10.1038/nrrheum.2010.86. Epub 2010 Jun 22. PMID: 20567251.
Tieppo Francio V, Davani S, Towery C, Brown TL. Oral Versus Topical Diclofenac Sodium in the Treatment of Osteoarthritis. J Pain Palliat Care Pharmacother. 2017 Jun;31(2):113-120. doi: 10.1080/15360288.2017.1301616. Epub 2017 Apr 7. PMID: 28388238.
Huang H, Luo M, Liang H, Pan J, Yang W, Zeng L, Liang G, Hou S, Zhao J, Liu J. Meta-analysis Comparing Celecoxib with Diclofenac Sodium in Patients with Knee Osteoarthritis. Pain Med. 2021 Feb 23;22(2):352-362. doi: 10.1093/pm/pnaa230. PMID: 32797224; PMCID: PMC7901859.
McCormack PL, Scott LJ. Diclofenac sodium injection (Dyloject): in postoperative pain. Drugs. 2008;68(1):123-30. doi: 10.2165/00003495-200868010-00008. Erratum in: Drugs. 2008;68(6):801. PMID: 18081376.
Brogden RN, Heel RC, Pakes GE, Speight TM, Avery GS. Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin. Drugs. 1980 Jul;20(1):24-48. doi: 10.2165/00003495-198020010-00002. PMID: 6772422.
Ulubay M, Yurt KK, Kaplan AA, Atilla MK. The use of diclofenac sodium in urological practice: A structural and neurochemical based review. J Chem Neuroanat. 2018 Jan;87:32-36. doi: 10.1016/j.jchemneu.2017.02.005. Epub 2017 Feb 6. PMID: 28179185.
Bertolini A, Ottani A, Sandrini M. Dual acting anti-inflammatory drugs: a reappraisal. Pharmacol Res. 2001 Dec;44(6):437-50. doi: 10.1006/phrs.2001.0872. PMID: 11735348.
State Register of Medicinal Products of Ukraine. Electronic resource - http://www.drlz.com.ua/
Pharmacoeconomic Guidelines Around The World. International society for pharmacoeconomics and outcome research. Available at www.ispor.org/ peguidelines/index.asp.
Опубліковано
Як цитувати
Номер
Розділ
Ліцензія
Авторське право (c) 2023 Автори
Ця робота ліцензується відповідно до Creative Commons Attribution 4.0 International License.
